K

Krensavage Asset Management, LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Krensavage Asset Management, LLC with $199.9M in long positions as of Q3 2025, 100% allocated to Healthcare, and 95% concentrated in top 10 positions.

Portfolio Value
$199.9M
Top 10 Concentration
95%
Top Sector
Healthcare (100%)
US Exposure
79%
Market Cap Focus
Large Cap
Countries
2

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 100.00%Healthcare
Healthcare
100.00%

Industry Breakdown

4 industries across all sectors

Biotechnology: 73.11%BiotechnologyDrug Manufacturers - Specialty & Generic: 20.40%Drug Manufacturers - Specialty & GenericMedical - Distribution: 5.79%Drug Manufacturers - General: 0.70%
Biotechnology
Healthcare
73.11%
Drug Manufacturers - Specialty & Generic
Healthcare
20.40%
Medical - Distribution
Healthcare
5.79%
Drug Manufacturers - General
Healthcare
0.70%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Large Cap ($10B - $200B): 49.80%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 26.97%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 7.61%Micro Cap ($50M - $300M): 15.61%Micro Cap ($50M - $300M)
Large Cap ($10B - $200B)
49.80%
Mid Cap ($2B - $10B)
26.97%
Small Cap ($300M - $2B)
7.61%
Micro Cap ($50M - $300M)
15.61%

Portfolio Concentration

Top 10 Holdings %
94.92%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
78.51%
International
21.49%
Countries
2
Largest Int'l Market
Ireland - 21.49%
United States of America
78.51% ($156.9M)
11 holdings
Ireland
21.49% ($42.9M)
3 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
15.3 quarters
Avg. Top 20
11.4 quarters
Avg. All Positions
11.4 quarters
Median Holding Period
4.5 quarters
Persistence Rate
57.14%
Persistent Holdings Weight
70.88%
Persistent Positions
8
Longest Held
United Therapeutics Corp logo
United Therapeutics CorpUTHR - 43 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
5.65%
Avg. Position Weight
7.14%
Largest Position
United Therapeutics Corp logo
United Therapeutics CorpUTHR - 20.48%
Largest Ownership Stake
Enanta Pharmaceuticals, Inc logo
Enanta Pharmaceuticals, IncENTA - 9.89%
Avg. Ownership Stake
1.58%
Ownership Stake >5%
1
Ownership Stake >1%
2

Historical (Since Q4 2014)

Avg. New Position
6.51%
Avg. Ownership Stake
0.99%
Largest Position
Enanta Pharmaceuticals, Inc logo
Enanta Pharmaceuticals, IncENTA - 23.35% (Q4 2017)
Largest Ownership Stake
Enanta Pharmaceuticals, Inc logo
Enanta Pharmaceuticals, IncENTA - 9.99% (Q4 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
15.9%
Value Traded
$31.87M
Positions Added
2
Positions Exited
1

Historical (Since Q4 2014)

Avg. Turnover Ratio
10.0%
Avg. Positions Added
1
Avg. Positions Exited
1
Highest Turnover
50.0%
Q4 2014
Lowest Turnover
0.5%
Q1 2016

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.